These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15782689)

  • 21. Intensive monitoring of new drugs based on first prescription signals from pharmacists: a pilot study.
    van Grootheest AC; Groote JK; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2003 Sep; 12(6):475-81. PubMed ID: 14513661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of patients' experiences with antidepressants reported by means of a medicine reporting system.
    van Geffen EC; van der Wal SW; van Hulten R; de Groot MC; Egberts AC; Heerdink ER
    Eur J Clin Pharmacol; 2007 Dec; 63(12):1193-9. PubMed ID: 17874086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterials: spontaneous report analysis for a six years period in Bulgaria.
    Getov I; Dimitrova Z
    Boll Chim Farm; 1999 Apr; 138(4):186-90. PubMed ID: 10422330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ADR related questions received by a telephone medicines information service and ADRs received by a spontaneous ADR reporting system: a comparison regarding patients and drugs.
    Egberts AC; de Koning FH; Meyboom RH; Leufkens HG
    Pharmacoepidemiol Drug Saf; 1997 Jul; 6(4):269-76. PubMed ID: 15073778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Objective registration and interpretation of adverse events caused by vaccines: an essential element of vaccination].
    Boot HJ
    Ned Tijdschr Geneeskd; 2007 Dec; 151(49):2707-8. PubMed ID: 18225788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.
    Shalviri G; Mohammad K; Majdzadeh R; Gholami K
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1136-40. PubMed ID: 17705214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
    Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Side effects of tramadol: 12 years of experience in the Netherlands].
    Kabel JS; van Puijenbroek EP
    Ned Tijdschr Geneeskd; 2005 Apr; 149(14):754-7. PubMed ID: 15835626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance and challenges of studying marketed drugs: what is a phase IV study? Common clinical research designs, registries, and self-reporting systems.
    Glasser SP; Salas M; Delzell E
    J Clin Pharmacol; 2007 Sep; 47(9):1074-86. PubMed ID: 17766697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Official systems of pharmacovigilance in France and in Spain. Comparison of spontaneous reporting in two regional centers: Pays Basque and Bordeaux].
    Aguirre C; Haramburu F
    Therapie; 1995; 50(6):563-9. PubMed ID: 8745957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacovigilance in pharmacy practice].
    Duquet N
    J Pharm Belg; 2011 Dec; (4):97-103. PubMed ID: 22299235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [PSUR - Instrument for pharmacovigilance and patient safety. What pharmacists should know about periodic safety update reports].
    Strehl E
    Med Monatsschr Pharm; 2009 Sep; 32(9):347-9. PubMed ID: 19795697
    [No Abstract]   [Full Text] [Related]  

  • 33. [Users of a regional center of pharmacovigilance].
    Haramburu F; Abraham E; Bégaud B
    Therapie; 1993; 48(5):475-7. PubMed ID: 8146828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse reaction assessment in Thailand.
    Sriwatanakul K; Pothisiri P
    Med Toxicol; 1986; 1 Suppl 1():105-9. PubMed ID: 3821423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nurses are increasingly involved in pharmacovigilance in Sweden.
    Ulfvarson J; Mejyr S; Bergman U
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):532-7. PubMed ID: 17072915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacovigilance: a case of phantom ships and Russian roulette].
    Stricker BH
    Ned Tijdschr Geneeskd; 2002 Jul; 146(27):1258-61. PubMed ID: 12138668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
    Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
    Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
    Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacovigilance: education and continuing updating. The role of university institutes].
    Mariani L
    Clin Ter; 1998; 149(3):219-25. PubMed ID: 9842106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacovigilance as new direction of research].
    Gaszner G; Makkos Z; Gaszner P
    Neuropsychopharmacol Hung; 2005 Dec; 7(4):194-8. PubMed ID: 16496484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.